Also, dihexa can be delivered via parenteral routes of administration
Sources Food and Drug Administration (FDA): FDA Approves New Medication for Chronic Weight Management Molecular Metabolism Journal: Glucagon-like peptide 1 (GLP-1) American Gastroenterological Association (AGA): Biology of Incretins: GLP-1 and GIP Columbia Surgery: The Ozempic Effect: Everything You Need to Know About Medical Weight Loss Eli Lilly: Tirzepatide demonstrated significant and superior weight loss compared to placebo in two pivotal studies American Diabetes Association (ADA): Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes Important Medical Information and Disclaimers Important Current Status Update : As of March 19, 2025, the FDA has ended enforcement discretion for compounded tirzepatide
General anti-aging serum: Community and commercial formulations commonly fall in the 0.1-0.5% range, bridging the clinical trial concentrations for skin aging and wound healing applications
Contraindicated in type 1 diabetes, diabetic ketoacidosis, personal/family history of medullary thyroid carcinoma or MEN 2 syndrome
To find out more about the wellness, beauty, and health benefits we provide at Simple IV, call us today at 626-998-3129
Purhonen, A